Recruiting
Contraception+1
RecruitingContraceptive efficacy, safety and tolerability of drospirenone 4 mg (LPRI‑CF113) in healthy women of reproductive age over 13 cycles
InvestigationalNo placebo
Contraceptive efficacy, safety and tolerability of drospirenone 4 mg (LPRI‑CF113) in healthy women of reproductive age over 13 cycles
InvestigationalNo placebo
- Disease:ContraceptionOral contraception
- Substances:Drospirenone
Countries:
Czechia
Czechia- Participants:0–17 years · 18–64 years · Healthy volunteers
- Substances:Drospirenone
- Sponsor:Chemo Research S.L.





